AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 157 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $739,000 | -3.7% | 48,874 | -42.0% | 0.02% | -11.1% |
| Q1 2022 | $767,000 | +111.9% | 84,335 | +63.4% | 0.02% | +200.0% |
| Q4 2021 | $362,000 | -54.3% | 51,599 | -25.7% | 0.01% | -53.8% |
| Q3 2021 | $792,000 | +16.6% | 69,491 | +82.9% | 0.01% | -7.1% |
| Q1 2021 | $679,000 | +207.2% | 37,989 | +153.6% | 0.01% | +27.3% |
| Q2 2020 | $221,000 | +52.4% | 14,977 | +39.1% | 0.01% | -15.4% |
| Q1 2020 | $145,000 | -75.7% | 10,767 | -65.3% | 0.01% | -35.0% |
| Q3 2019 | $597,000 | +20.6% | 31,049 | +85.4% | 0.02% | +42.9% |
| Q2 2019 | $495,000 | -7.5% | 16,744 | +52.1% | 0.01% | 0.0% |
| Q3 2017 | $535,000 | +6.6% | 11,010 | +15.2% | 0.01% | -6.7% |
| Q2 2017 | $502,000 | -21.7% | 9,561 | -43.7% | 0.02% | 0.0% |
| Q3 2016 | $641,000 | – | 16,990 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |